Atrolak
Atrolak contains Ketorolac Tromethamine, a potent nonsteroidal anti-inflammatory drug (NSAID). It works by inhibiting the cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins which are responsible for causing pain, fever, and inflammation. The systemic forms are used for short-term pain relief, while the ophthalmic form is used to manage eye pain and swelling after surgery or due to allergies.
Dosage by Body Weight
Systemic treatment (oral/injectable) must not exceed 5 days due to the risk of severe renal and gastrointestinal side effects. For eye drops, the typical dose is 1 drop in the affected eye(s) four times daily. Dosage must be strictly determined and supervised by a qualified healthcare professional.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients of this weight.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Avoid use unless explicitly prescribed and closely monitored by a pediatric specialist.
- Body Weight
- 8-10 kg
- Dose
- 0.25 mg/kg to 0.5 mg/kg (Single dose only)
- Frequency
- Single dose or as directed by a specialist
- Tracking Notes
- Oral formulations are generally avoided; used only in clinical settings under strict supervision.
- Body Weight
- 11-15 kg
- Dose
- 0.25 mg/kg orally or 0.5 mg/kg IV/IM
- Frequency
- Every 6 hours as needed (Maximum 5 days)
- Tracking Notes
- Use with extreme caution. Ensure patient is well-hydrated to minimize risk of renal toxicity.
- Body Weight
- 16-20 kg
- Dose
- 0.25 mg/kg orally or 0.5 mg/kg IV/IM
- Frequency
- Every 6 hours as needed (Maximum 5 days)
- Tracking Notes
- Monitor closely for gastrointestinal bleeding, renal dysfunction, or hypersensitivity reactions.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not administer | Safety and efficacy have not been established in pediatric patients of this weight. |
| 5-7 kg | Not recommended | Do not administer | Avoid use unless explicitly prescribed and closely monitored by a pediatric specialist. |
| 8-10 kg | 0.25 mg/kg to 0.5 mg/kg (Single dose only) | Single dose or as directed by a specialist | Oral formulations are generally avoided; used only in clinical settings under strict supervision. |
| 11-15 kg | 0.25 mg/kg orally or 0.5 mg/kg IV/IM | Every 6 hours as needed (Maximum 5 days) | Use with extreme caution. Ensure patient is well-hydrated to minimize risk of renal toxicity. |
| 16-20 kg | 0.25 mg/kg orally or 0.5 mg/kg IV/IM | Every 6 hours as needed (Maximum 5 days) | Monitor closely for gastrointestinal bleeding, renal dysfunction, or hypersensitivity reactions. |
Formulation
Purpose
Used for the short-term management of moderate to severe acute pain, post-operative ocular pain, and reduction of ocular itching and inflammation associated with seasonal allergic conjunctivitis.
Generic Name
Ketorolac TromethamineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.